Skip to main content
. 2015 Jun 29;51(1):167–186. doi: 10.1111/1475-6773.12328

Table 2.

Medicare Expenditures on Breast Cancer–Related Care across Hospital Referral Regions (HRRs)

Cost Component All HRRs HRR Quintiles, Based on Average per Patient Medicare Expenditure on Initial Breast Cancer Care Difference between Quintile 1 and Quintile 5
Mean Standard Deviation 1 (Lowest) 2 3 4 5 (Highest)
Total expenditure—cases $29,452 $3,773 $24,617 $28,077 $29,861 $31,207 $34,062 $9,445
Total expenditure—controls $10,200 $1,889 $9,546 $10,328 $10,365 $10,203 $10,584 $1,038
Total breast cancer–related expenditurea $19,255 $2,977 $15,053 $17,760 $19,525 $20,993 $23,480 $8,427
Surgery $6,527 $755 $6,074 $6,299 $6,634 $6,736 $6,939 $865
Radiation therapy $5,828 $1,389 $5,066 $5,432 $5,624 $6,389 $6,790 $1,724
Systemic therapy $2,702 $911 $2,017 $2,722 $2,631 $2,974 $3,247 $1,230
Growth factors $1,558 $602 $1,138 $1,520 $1,456 $1,752 $1,997 $859
Imaging services $831 $246 $713 $777 $855 $922 $898 $185
Other expenditures $1,805 $1,599 $63 $1,000 $2,297 $2,231 $3,605 $3,542

Expenditures reflect inflation adjusted constant 2009 U.S. dollars and after removing regional differences in input prices. HRR quintiles were assigned based on simulated results from a hierarchical generalized linear regression model with no covariates but separate intercepts for cases and controls and HRR random effects for cases and controls to account for clustering in data within HRRs (Model 0).

a

For each HRR, the average per person expenditure on breast cancer–related care reflects the difference in mean expenditure between cases and controls.